488 related articles for article (PubMed ID: 15809018)
1. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
[TBL] [Abstract][Full Text] [Related]
2. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
3. Progesterone but not estradiol 17beta potentiates local GH secretions by hormone-dependent breast cancer explants. An in vitro study.
Milewicz T; Gregoraszczuk EL; Augustowska K; Krzysiek J; Sztefko K; Ryś J
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):127-32. PubMed ID: 15772906
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
[TBL] [Abstract][Full Text] [Related]
5. The impact of progesterone on simultaneous, local secretion of IGFBP-3 and IGF-I [IGFBP-3/IGF-I index] by human malignant and non-malignant breast explants depends on tissue steroid receptor phenotype.
Krzysiek J; Milewicz T; Augustowska K; Sztefko K; Ryś J; Zubel A; Pityński K; Jaszczyński P; Herman K; Basta A; Stachura J; Gregoraszczuk EŁ
Ginekol Pol; 2003 Sep; 74(9):767-74. PubMed ID: 14674122
[TBL] [Abstract][Full Text] [Related]
6. The influence of insulin on secretion of IGF-I and IGFBP-I in cultures of human endometrial stromal cells.
Lin J; Li R; Zhou J
Chin Med J (Engl); 2003 Feb; 116(2):301-4. PubMed ID: 12775252
[TBL] [Abstract][Full Text] [Related]
7. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messenger ribonucleic acids in the primate myometrium.
Adesanya OO; Zhou J; Bondy CA
J Clin Endocrinol Metab; 1996 Jul; 81(7):2495-501. PubMed ID: 8675566
[TBL] [Abstract][Full Text] [Related]
8. Oestradiol-17beta inhibits tamoxifen-induced LHRH self-priming blocking hormone-dependent and ligand-independent activation of the gonadotrope progesterone receptor in the rat.
Sánchez-Criado JE; Garrido-Gracia JC; Bellido C; Aguilar R; Guelmes P; Abreu P; Alonso R; Barranco I; Millán Y; de Las Mulas JM
J Endocrinol; 2006 Jul; 190(1):73-84. PubMed ID: 16837612
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
[TBL] [Abstract][Full Text] [Related]
10. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
11. Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.
Grønbaek H; Tanos V; Meirow D; Peretz T; Raz I; Flyvbjerg A
Anticancer Res; 2003; 23(3C):2815-20. PubMed ID: 12926118
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
13. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
[TBL] [Abstract][Full Text] [Related]
14. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
Kawamura I; Lacey E; Mizota T; Tsujimoto S; Nishigaki F; Manda T; Shimomura K
Anticancer Res; 1994; 14(2A):427-31. PubMed ID: 8017842
[TBL] [Abstract][Full Text] [Related]
15. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
16. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status.
Figueroa JA; Jackson JG; McGuire WL; Krywicki RF; Yee D
J Cell Biochem; 1993 Jun; 52(2):196-205. PubMed ID: 7690042
[TBL] [Abstract][Full Text] [Related]
18. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression.
Huynh H; Pollak M
Cancer Res; 1994 Jun; 54(12):3115-9. PubMed ID: 7515764
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional profiles of progestogen effects in the postmenopausal breast.
Wood CE; Register TC; Cline JM
Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]